We further investigated the prognostic value of Dectin-1+ cells in GC and found that patients with high infiltration of Dectin-1+ cells had significantly poorer OS and DFS than those with low infiltration of Dectin-1+ cells in both the Discovery set and Validation set (Fig. 1e, f). The gene discussed is CLEC7A; the disease is gastric cancer.